Menu
Currency
GWAS Study

Helicobacter pylori Treatment and Gastric Cancer Risk Among Individuals With High Genetic Risk for Gastric Cancer.

Xu HM, Han Y, Liu ZC et al.

38809553 PubMed ID
GWAS Study Type
2816 Participants
87 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

XH
Xu HM
HY
Han Y
LZ
Liu ZC
YZ
Yin ZY
WM
Wang MY
YC
Yu C
MJ
Ma JL
SD
Sun D
LW
Liu WD
ZY
Zhang Y
ZT
Zhou T
ZJ
Zhang JY
PP
Pei P
YL
Yang L
MI
Millwood IY
WR
Walters RG
CY
Chen Y
DH
Du H
CZ
Chen Z
YW
You WC
LL
Li L
PK
Pan KF
LJ
Lv J
LW
Li WQ
Chapter II

Abstract

Summary of the research findings

Importance: Helicobacter pylori treatment and nutrition supplementation may protect against gastric cancer (GC), but whether the beneficial effects only apply to potential genetic subgroups and whether high genetic risk may be counteracted by these chemoprevention strategies remains unknown.

2,816 East Asian ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

2816
Total Participants
GWAS
Study Type
No
Replicated
East Asian
Ancestry
China
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.